Your browser doesn't support javascript.
loading
Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry.
Martinez-Morilla, Sandra; Villarroel-Espindola, Franz; Wong, Pok Fai; Toki, Maria I; Aung, Thazin Nwe; Pelekanou, Vasiliki; Bourke-Martin, Brian; Schalper, Kurt A; Kluger, Harriet M; Rimm, David L.
Affiliation
  • Martinez-Morilla S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Villarroel-Espindola F; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Wong PF; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Toki MI; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Aung TN; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Pelekanou V; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Bourke-Martin B; Navigate BioPharma Services, Inc., Carlsbad, California.
  • Schalper KA; Department of Pathology, Yale School of Medicine, New Haven, Connecticut.
  • Kluger HM; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
  • Rimm DL; Department of Pathology, Yale School of Medicine, New Haven, Connecticut. david.rimm@yale.edu.
Clin Cancer Res ; 27(7): 1987-1996, 2021 04 01.
Article in En | MEDLINE | ID: mdl-33504554

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Image Cytometry / Tumor Microenvironment / Immune Checkpoint Inhibitors / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Image Cytometry / Tumor Microenvironment / Immune Checkpoint Inhibitors / Melanoma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2021 Type: Article